Thus, the potent contributions of TGF-β1 in airway remodeling and pulmonary fibrosis, make it an effective target to attenuate these effects by either specific microRNA [96] or specific inhibitors [99]. This evidence concerns the gene TGFB1 and pulmonary fibrosis.